Amgen (AMGN) FCF Margin (QoQ) (2009 - 2026)
Amgen (AMGN) FCF Margin (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.95 Bn | 632.19 Bn | 17.26 Bn |
| 2 | AbbVie | 469.97 Bn | 463.40 Bn | 12.70 Bn |
| 3 | Merck | 377.05 Bn | 369.90 Bn | 12.21 Bn |
| 4 | Novartis Ag | 302.66 Bn | 294.97 Bn | 11.24 Bn |
| 5 | Astrazeneca | 258.09 Bn | 253.19 Bn | 12.86 Bn |
| 6 | Amgen | 236.99 Bn | 223.00 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 183.08 Bn | 179.90 Bn | 6.22 Bn |
| 8 | Pfizer | 160.54 Bn | 148.84 Bn | 10.94 Bn |
| 9 | Gsk | 106.06 Bn | 101.89 Bn | 8.24 Bn |
| 10 | Sanofi | 55.32 Bn | 47.94 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,756.00 |
| Mar 31, 2026 | 740.00 |
| Dec 31, 2025 | -3,471.00 |
| Sep 30, 2025 | 2,363.00 |
| Jun 30, 2025 | 879.00 |
| Mar 31, 2025 | -3,640.00 |
| Dec 31, 2024 | 945.00 |
| Sep 30, 2024 | 1,250.00 |
| Jun 30, 2024 | 2,031.00 |
| Mar 31, 2024 | 264.00 |
| Dec 31, 2023 | -3,286.00 |
| Sep 30, 2023 | -1,855.00 |
| Jun 30, 2023 | 4,314.00 |
| Mar 31, 2023 | -49,126.00 |
| Dec 31, 2022 | 46,069.00 |
| Sep 30, 2022 | 1,682.00 |
| Jun 30, 2022 | -611.00 |
| Mar 31, 2022 | -518.00 |
| Dec 31, 2021 | 438.00 |
| Sep 30, 2021 | 569.00 |